| Ms Mckenna Lynne Emmerich, MA, NCC | |
|
300 N Washington St Ste 500, Alexandria, VA 22314-2535 | |
| (703) 518-8883 | |
| Not Available |
| Full Name | Ms Mckenna Lynne Emmerich |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 300 N Washington St Ste 500, Alexandria, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093462921 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Mckenna Lynne Emmerich, MA, NCC 300 N Washington St Ste 500, Alexandria, VA 22314-2535 Ph: (703) 518-8883 | Ms Mckenna Lynne Emmerich, MA, NCC 300 N Washington St Ste 500, Alexandria, VA 22314-2535 Ph: (703) 518-8883 |
News Archive
Heart researchers at Columbia University Medical Center have developed and tested a unique heart arrhythmia drug that could prevent the sudden death of millions of people with heart failure as well as people with an inherited heart disorder. The drug represents one of the first molecular-based therapies for heart failure and avoids the toxicity of current treatments.
Competitive gymnasts have a higher exposure to potentially harmful flame-retardants than the general population, likely because such contaminants are present in foam used in gym equipment, a study led by Boston University School of Public Health researchers has found.
More than 15 years ago, David Warshaw, Ph.D., and coworkers discovered the precise malfunction of a specific protein in the heart that leads to hypertrophic cardiomyopathy, a common culprit in cases of sudden death in young athletes.
Eli Lilly and Company has received its third U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab).
Vicept™ Therapeutics Inc., a privately held specialty biopharmaceutical company dedicated to developing the first effective topically applied therapy for erythema (facial redness) of rosacea, announced that it has secured $10 million to complete a total $16 million Series A financing. The Series A was led by Vivo Ventures, Sofinnova Ventures and Fidelity Biosciences.
› Verified 6 days ago
Dr. John-paul James, PH.D., D.MIN., DACBN Counselor Medicare: Not Enrolled in Medicare Practice Location: 2800 Eisenhower Ave, Alexandria, VA 22314 Phone: 240-383-4800 Fax: 240-846-1533 | |
Mrs. Kasey Lynn Gordon Cain, RESIDENT INCOUNSELIG Counselor Medicare: Not Enrolled in Medicare Practice Location: 2850 Eisenhower Ave, Alexandria, VA 22314 Phone: 703-991-6005 | |
Amber Ferguson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2800 Eisenhower Ave Ste 200, Alexandria, VA 22314 Phone: 703-562-9220 Fax: 703-520-7745 | |
Qi Chen, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3361 Beechcliff Dr, Alexandria, VA 22306 Phone: 970-889-9295 | |
Karin Layne, QMHP, CASAC-S Counselor Medicare: Not Enrolled in Medicare Practice Location: 205 S Whiting St Ste 600, Alexandria, VA 22304 Phone: 571-257-8631 Fax: 571-231-4304 | |
Ms. Lynn Marie Fritts, Counselor Medicare: Not Enrolled in Medicare Practice Location: 720 N Saint Asaph St, Alexandria, VA 22314 Phone: 703-838-6400 Fax: 703-838-5062 | |
Lina Cuda, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 720 N Saint Asaph St, Alexandria, VA 22314 Phone: 703-746-3444 Fax: 703-746-3464 |